ArticleCureus2025
Optimal Frequency for Cranial Electromagnetic Field Stimulation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Glymphatic System Visualized With Intrathecal Gadoterate Meglumine Administered via External Ventricular Drain.Cureus · 2026Article
- Article
- Progress to Date on Cranial Electromagnetic Field Stimulation to Modulate Brain Activity.Cureus · 2025Article
- Optimal Voltage for Cranial Electromagnetic Field Stimulation to Modulate Brain Activity.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Communication among neurons generates electromagnetic fields (EMFs) that can be measured through a noninvasive, portable helmet equipped with 20 sensors. The EMF data reveal a variety of EMF patterns that have yet to be elucidated. Understanding a propagated frequency from the brain and its subunits can assist with diagnosing the brain and its subunits' function and treatment. Here, the authors provide an interpretation of the EMF patterns with an emphasis on frequency. Methods From January 2025 to February 2025, a prospective clinical study was conducted to enroll patients greater than 18 years old diagnosed with atraumatic and traumatic brain injury whose EMFs, which were collected using a helmet equipped with 20 sensors, were obtained within 24 hours of presentation. EMF data were collected using DAQami software (DATAQ Instruments Inc., Akron, Ohio, United States) and analyzed using fast Fourier transformation with Igor Pro 8 software (WaveMetrics Inc., Lake Oswego, Oregon, United States). Based on each patient's clinical presentations and/or radiographic findings, the sensors of interest, their opposing sensors, and frequencies of interest (FOIs) were selected. Results A total of 10 patients were enrolled with a mean age of 47.1 years. Mechanisms of injury included spontaneous hypertensive intracranial hemorrhage (one patient) and head trauma after a motor vehicle collision, dirt bike accident, or ground-level fall (nine patients). Radiographic findings included spontaneous basal ganglia hemorrhage (one patient), isolated traumatic subdural hematoma (one patient), traumatic subarachnoid hemorrhage (one patient), and no intracranial abnormalities (seven patients). The following targeted FOIs were found: 5.2 Hz, 7.3 Hz, 7.6 Hz, 7.7 Hz, 7.9 Hz, 8.3 Hz, 8.6 Hz, 8.7 Hz, 9.5 Hz, and 10.4 Hz. Conclusions EMF of the human brain reveals changes in neuronal activities in atraumatic and traumatic brain injury patients. This information allows for the localization of sites of brain injuries and the selection of frequencies that can be used for understanding the EMF frequency and function on the macroscopic level as well as at the cellular level. This specific information can then be utilized for stimulation to modulate the changes in neuronal, circuit, and brain function activities. Our frequency selection technique enables more precise, tailored, and potentially more effective treatment aiming to restore EMF activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.